NYSE:SYKStryker Stock Price, Forecast & News

Stryker's stock was trading at $175.62 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SYK shares have increased by 4.7% and is now trading at $183.94. View which stocks have been most impacted by Coronavirus.

27 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 2 sell ratings, 7 hold ratings, 17 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Stryker.

Stryker is scheduled to release its next quarterly earnings announcement on Thursday, July 30th 2020. View our earnings forecast for Stryker.

Stryker will be holding an earnings conference call on Thursday, July 30th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Stryker Co. (NYSE:SYK) posted its earnings results on Thursday, April, 30th. The medical technology company reported $1.84 earnings per share for the quarter, beating the consensus estimate of $1.69 by $0.15. The medical technology company had revenue of $3.59 billion for the quarter, compared to analysts' expectations of $3.45 billion. Stryker had a net margin of 14.47% and a return on equity of 24.90%. Stryker's quarterly revenue was up 2.0% on a year-over-year basis. During the same quarter last year, the company posted $1.88 EPS. View Stryker's earnings history.

Stryker declared a quarterly dividend on Tuesday, May 5th. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.575 per share on Friday, July 31st. This represents a $2.30 annualized dividend and a yield of 1.25%. The ex-dividend date is Monday, June 29th. View Stryker's dividend history.

27 brokers have issued twelve-month price targets for Stryker's stock. Their forecasts range from $150.00 to $248.00. On average, they anticipate Stryker's share price to reach $215.20 in the next twelve months. This suggests a possible upside of 17.0% from the stock's current price. View analysts' price targets for Stryker.

Media headlines about SYK stock have been trending negative recently, InfoTrie reports. The research firm scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Stryker earned a news sentiment score of -2.8 on InfoTrie's scale. They also gave news coverage about the medical technology company a news buzz of 7.0 out of 10, meaning that recent media coverage is likely to have an effect on the stock's share price in the immediate future. View the latest news about Stryker.

Stryker saw a decrease in short interest in the month of June. As of June 15th, there was short interest totaling 3,130,000 shares, a decrease of 24.0% from the May 31st total of 4,120,000 shares. Based on an average daily volume of 2,390,000 shares, the days-to-cover ratio is presently 1.3 days. Approximately 0.9% of the shares of the company are short sold. View Stryker's Current Options Chain.

Some companies that are related to Stryker include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Becton Dickinson and (BDX), Boston Scientific (BSX), Baxter International (BAX), Edwards Lifesciences (EW), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Hologic (HOLX), Steris (STE), Masimo (MASI) and Insulet (PODD). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Walt Disney (DIS), Medtronic (MDT), Johnson & Johnson (JNJ), Home Depot (HD), AbbVie (ABBV), Abbott Laboratories (ABT), Visa (V), Alibaba Group (BABA), Bank of America (BAC) and NVIDIA (NVDA).

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Stryker's stock is owned by a variety of retail and institutional investors. Top institutional investors include Confluence Investment Management LLC (0.09%), First Financial Bank Trust Division (0.01%), Park National Corp OH (0.01%), Smithbridge Asset Management Inc. DE (0.00%) and M&R Capital Management Inc. (0.00%). Company insiders that own Stryker stock include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Roch Doliveux, Srikant M Datar, Timothy J Scannell and Yin C Becker. View institutional ownership trends for Stryker.

SYK stock was purchased by a variety of institutional investors in the last quarter, including Park National Corp OH, First Financial Bank Trust Division, Confluence Investment Management LLC, M&R Capital Management Inc., and Smithbridge Asset Management Inc. DE. View insider buying and selling activity for Stryker.

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SYK stock can currently be purchased for approximately $183.94.

Stryker has a market capitalization of $68.95 billion and generates $14.88 billion in revenue each year. The medical technology company earns $2.08 billion in net income (profit) each year or $8.26 on an earnings per share basis. Stryker employs 40,000 workers across the globe.

The official website for Stryker is www.strykercorp.com.

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected]